My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 172

    3.

    EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors.

    Stevens L, Zhang W, Peck L, Kuczek T, Grevstad N, Mahon A, Zentall SS, Arnold LE, Burgess JR.

    Lipids. 2003 Oct;38(10):1007-21.PMID: 14669965 [PubMed - indexed for MEDLINE]Related articles

    4.

    Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n-3 fatty acids containing phospholipids.

    Vaisman N, Kaysar N, Zaruk-Adasha Y, Pelled D, Brichon G, Zwingelstein G, Bodennec J.

    Am J Clin Nutr. 2008 May;87(5):1170-80.PMID: 18469236 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder.

    Voigt RG, Llorente AM, Jensen CL, Fraley JK, Berretta MC, Heird WC.

    J Pediatr. 2001 Aug;139(2):189-96.PMID: 11487742 [PubMed - indexed for MEDLINE]Related articles

    7.

    Plasma, red blood cells phospholipids and clinical evaluation after long chain omega-3 supplementation in children with attention deficit hyperactivity disorder (ADHD).

    Germano M, Meleleo D, Montorfano G, Adorni L, Negroni M, Berra B, Rizzo AM.

    Nutr Neurosci. 2007 Feb-Apr;10(1-2):1-9.PMID: 17539477 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder - a placebo-controlled double-blind study.

    Hirayama S, Hamazaki T, Terasawa K.

    Eur J Clin Nutr. 2004 Mar;58(3):467-73.PMID: 14985685 [PubMed - indexed for MEDLINE]Related articles

    10.

    Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids.

    Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY.

    Clin Chem. 2006 Dec;52(12):2265-72. Epub 2006 Oct 19.PMID: 17053155 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Efficacy of omega-3 fatty acids in children and adults with IgA nephropathy is dosage- and size-dependent.

    Hogg RJ, Fitzgibbons L, Atkins C, Nardelli N, Bay RC; North American IgA Nephropathy Study Group.

    Clin J Am Soc Nephrol. 2006 Nov;1(6):1167-72. Epub 2006 Sep 27.PMID: 17699343 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects.

    Buckley R, Shewring B, Turner R, Yaqoob P, Minihane AM.

    Br J Nutr. 2004 Sep;92(3):477-83.PMID: 15469651 [PubMed - indexed for MEDLINE]Related articles

    13.

    Differential effects of eicosapentaenoic and docosahexaenoic acids upon oxidant-stimulated release and uptake of arachidonic acid in human lymphoma U937 cells.

    Obajimi O, Black KD, MacDonald DJ, Boyle RM, Glen I, Ross BM.

    Pharmacol Res. 2005 Aug;52(2):183-91.PMID: 15967385 [PubMed - indexed for MEDLINE]Related articles

    14.

    Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation.

    Clayton EH, Hanstock TL, Hirneth SJ, Kable CJ, Garg ML, Hazell PL.

    Eur J Clin Nutr. 2009 Aug;63(8):1037-40. Epub 2009 Jan 21.PMID: 19156158 [PubMed - indexed for MEDLINE]Related articles

    15.

    The effects of docosahexaenoic acid-rich fish oil on behavior, school attendance rate and malaria infection in school children--a double-blind, randomized, placebo-controlled trial in Lampung, Indonesia.

    Hamazaki K, Syafruddin D, Tunru IS, Azwir MF, Asih PB, Sawazaki S, Hamazaki T.

    Asia Pac J Clin Nutr. 2008;17(2):258-63.PMID: 18586645 [PubMed - indexed for MEDLINE]Related articles

    16.

    No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial.

    Rogers PJ, Appleton KM, Kessler D, Peters TJ, Gunnell D, Hayward RC, Heatherley SV, Christian LM, McNaughton SA, Ness AR.

    Br J Nutr. 2008 Feb;99(2):421-31. Epub 2007 Oct 24.PMID: 17956647 [PubMed - indexed for MEDLINE]Related articles

    17.

    Supplementation of arachidonic acid plus docosahexaenoic acid in cirrhotic patients awaiting liver transplantation: a preliminary study.

    Pazirandeh S, Ling PR, Ollero M, Gordon F, Burns DL, Bistrian BR.

    JPEN J Parenter Enteral Nutr. 2007 Nov-Dec;31(6):511-6.PMID: 17947609 [PubMed - indexed for MEDLINE]Related articles

    18.

    Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.

    Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.

    Clin Ther. 2007 Jun;29(6):1168-77.PMID: 17692731 [PubMed - indexed for MEDLINE]Related articles

    19.

    Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.

    Saifullah A, Watkins BA, Saha C, Li Y, Moe SM, Friedman AN.

    Nephrol Dial Transplant. 2007 Dec;22(12):3561-7. Epub 2007 Jul 10.PMID: 17623719 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder.

    Kratochvil CJ, Vaughan BS, Mayfield-Jorgensen ML, March JS, Kollins SH, Murray DW, Ravi H, Greenhill LL, Kotler LA, Paykina N, Biggins P, Stoner J.

    J Child Adolesc Psychopharmacol. 2007 Apr;17(2):175-85.PMID: 17489712 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk